BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19672150)

  • 1. Comparison of carbon ions versus protons.
    Weber U; Kraft G
    Cancer J; 2009; 15(4):325-32. PubMed ID: 19672150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between in-beam and offline positron emission tomography imaging of proton and carbon ion therapeutic irradiation at synchrotron- and cyclotron-based facilities.
    Parodi K; Bortfeld T; Haberer T
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):945-56. PubMed ID: 18514787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical physics aspects of particle therapy.
    Jäkel O
    Radiat Prot Dosimetry; 2009 Nov; 137(1-2):156-66. PubMed ID: 19828718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
    Weber DC; Trofimov AV; Delaney TF; Bortfeld T
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons.
    Peeters A; Grutters JP; Pijls-Johannesma M; Reimoser S; De Ruysscher D; Severens JL; Joore MA; Lambin P
    Radiother Oncol; 2010 Apr; 95(1):45-53. PubMed ID: 20106540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particle radiation therapy using proton and heavier ion beams.
    Schulz-Ertner D; Tsujii H
    J Clin Oncol; 2007 Mar; 25(8):953-64. PubMed ID: 17350944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton radiotherapy for liver tumors: dosimetric advantages over photon plans.
    Wang X; Krishnan S; Zhang X; Dong L; Briere T; Crane CH; Martel M; Gillin M; Mohan R; Beddar S
    Med Dosim; 2008; 33(4):259-67. PubMed ID: 18973852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basics of particle therapy II biologic and dosimetric aspects of clinical hadron therapy.
    Rong Y; Welsh J
    Am J Clin Oncol; 2010 Dec; 33(6):646-9. PubMed ID: 20395789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and new developments in ion therapy.
    Karger CP; Jäkel O
    Strahlenther Onkol; 2007 Jun; 183(6):295-300. PubMed ID: 17520182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
    Baumert BG; Norton IA; Lomax AJ; Davis JB
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charged particle therapy: the physics of interaction.
    Lomax AJ
    Cancer J; 2009; 15(4):285-91. PubMed ID: 19672144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical experience with particle therapy in adults.
    Schulz-Ertner D
    Cancer J; 2009; 15(4):306-11. PubMed ID: 19672147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy systems using proton and carbon beams.
    Jongen Y
    Bull Mem Acad R Med Belg; 2008; 163(10-12):471-8; discussion 479-80. PubMed ID: 20120253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
    Palm A; Johansson KA
    Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.
    Feuvret L; Noel G; Weber DC; Pommier P; Ferrand R; De Marzi L; Dhermain F; Alapetite C; Mammar H; Boisserie G; Habrand JL; Mazeron JJ
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):944-54. PubMed ID: 17889276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of ion sources for medical accelerators (invited).
    Muramatsu M; Kitagawa A
    Rev Sci Instrum; 2012 Feb; 83(2):02B909. PubMed ID: 22380341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of optimized single and multifield irradiation plans of antiproton, proton and carbon ion beams.
    Bassler N; Kantemiris I; Karaiskos P; Engelke J; Holzscheiter MH; Petersen JB
    Radiother Oncol; 2010 Apr; 95(1):87-93. PubMed ID: 20304512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.